U.S.-based nutrition startup Berry Street has merged with Khosla Ventures-backed Indian healthtech startup Healthify as demand for GLP-1 drugs continues to grow among people seeking weight-loss solutions.
The companies have not disclosed the financial terms of the merger. However, a JPMorgan report published this year estimated that more than 30 million people in the U.S. could use GLP-1 drugs by 2030, highlighting the growing opportunity in the metabolic health market.
Following the merger, Berry Street founder Noah Kotlove and Healthify founder Tushar Vashisht will serve as co-CEOs of the combined company. In the U.S., the business will operate under the Berry Street name, while it will retain the Healthify brand in markets such as India.
Healthify has raised more than $150 million in funding, according to sources. The company operates an app that combines AI-powered technology with human fitness and nutrition coaching. Last year, Healthify expanded its U.S. operations and introduced GLP-1-supported programmes in India. The company claims that it has served more than 45 million customers to date.
“Healthify’s mission has been to put a dietitian in every human’s pocket. We have spent a decade proving that AI can drive life-changing outcomes at scale. Berry Street gives us the clinical backbone and the coverage infrastructure to deliver that promise to the U.S. market at a scale no one has achieved before,” Healthify’s CEO Vashisht said in a press release.
Meanwhile, Berry Street operates a network of more than 2,000 clinics and provides insurance-covered GLP-1 care. The company raised $50 million last year in a funding round led by Northzone, Sofina, and FJ Labs. In addition, Berry Street offers AI-powered nutrition coaching and meal-tracking services and claims to have served more than 200,000 people through collaborations with Amazon, Walmart, and other platforms.
The merger will therefore combine Healthify’s AI-driven nutrition and fitness capabilities with Berry Street’s clinical network and insurance infrastructure. Together, the companies aim to expand access to personalised metabolic health and GLP-1 care across the U.S.
“By pairing AI with a nationwide network of expert clinicians, Healthify and Berry Street are building the platform that will redefine metabolic care, giving everyone access to daily nutrition guidance and expert dietitian advice,” Khosla Ventures’ founder Vinod Khosla said in a statement.
As a result, the combined company will focus on integrating AI-powered nutrition guidance, human clinical expertise and GLP-1 treatment support. The deal also gives Healthify a broader platform to scale its technology and coaching model in the U.S. while allowing Berry Street to strengthen its digital nutrition capabilities.
